Expanding Chaetocin-Based Therapies to Novel Hearing Loss Prevention and Treatment Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of chaetocin-based compounds to prevent and treat hearing loss in new, high-impact industries, including aviation, military, music, construction, and sports.
Background and Problem Solved
While the original patent focuses on preventing and treating hearing loss caused by chemotherapeutic agents, this new inventive concept addresses the unmet need for effective hearing loss prevention and treatment solutions in diverse industries, where loud noise exposure is a significant occupational hazard.
Detailed Description of the Inventive Concept
The inventive concept involves administering chaetocin-based compounds to protect the inner ear cells from death caused by loud noise exposure in various settings. For instance, in pilots, chaetocin can be administered to prevent noise-induced hearing loss. In soldiers, a pharmaceutical composition comprising chaetocin can be administered prior to exposure to explosive noise. Similarly, in musicians, a topical composition comprising chaetocin can be applied to the outer ear to prevent hearing loss. In construction workers, a noise-cancelling earpiece with a dispenser for administering chaetocin can be used. In swimmers, a topical composition comprising chaetocin can be applied to the outer ear prior to swimming.
Novelty and Inventive Step
The new claims introduce novel applications of chaetocin-based compounds in diverse industries, which were not originally considered in the original patent. The inventive step lies in recognizing the potential of these compounds to prevent and treat hearing loss in these new settings, and developing specific formulations and delivery methods tailored to each industry's unique needs.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include using different analogs of chaetocin, varying the administration routes and dosages, or combining chaetocin with other therapeutic agents to enhance its efficacy. Additionally, the inventive concept can be adapted for use in other industries, such as manufacturing, emergency response, or transportation, where noise exposure is a significant risk.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including aviation, military, music, construction, and sports, where hearing loss prevention and treatment are critical concerns. The market for hearing loss prevention and treatment solutions is substantial, and this inventive concept offers a novel, effective, and targeted approach to addressing this need.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions for hearing protection, specifically focused on otoprotective agents and methods of preventing hearing loss across various noise exposure scenarios
Person of Ordinary Skill (PHOSITA) Profile
A pharmacologist or medical researcher with expertise in drug delivery, hearing protection technologies, and pharmaceutical formulations, possessing knowledge of noise-induced hearing loss mechanisms and protective compound strategies
Obviousness Rationale
A PHOSITA would recognize that the core mechanism of chaetocin for protecting inner ear cells from damage is universally applicable across different noise exposure contexts. The fundamental scientific principle of preventing cellular death through chaetocin remains consistent, regardless of the specific noise source or professional environment. The variations in administration method and target industry represent predictable design choices that would be obvious extensions of the original hearing loss prevention technology.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,551 |
|---|---|
| Title | Methods for the prevention and treatment of hearing loss |
| Assignee(s) | Ting Therapeutics LLC |